Internet of Things - IOT

This market insight focuses on the demand for different types of probiotics and enzymes in North America and Europe. The segments are split, based on the food applications. The price variations of probitoics and enzymes are provided, in addition to the market share of major participants. This market insight also covers the current competitive scena...

This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that ca...

This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...

This market insight on contract sales and marketing organisations throws light on the changing dynamics and the opportunities that lie ahead for these organisations in the future.

This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA i...

This research service provides insights into M&A activities, trends and strategic analysis in the pharma- biotech space.

This research service provides the market information on the global radiotherapy and radiosurgery markets, with specific focus on the United States.

This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifyin...

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, or...